# A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib on Metformin

> **NCT03826602** · PHASE1 · COMPLETED · sponsor: **Seagen Inc.** · enrollment: 18 (actual)

## Conditions studied

- Drug-drug Interaction

## Interventions

- **DRUG:** Tucatinib
- **DRUG:** Metformin
- **DRUG:** Iohexol

## Key facts

- **NCT ID:** NCT03826602
- **Lead sponsor:** Seagen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-12
- **Primary completion:** 2019-03-08
- **Final completion:** 2019-03-15
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03826602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03826602, "A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib on Metformin". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03826602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*